Prometheus has announced a significant funding round, raising $12 billion to further its initiatives in artificial engineering within the biotechnology field.
This investment is part of a broader trend in the biotech industry, which includes the recent acquisition of a cancer drug by the nonprofit Blood Cancer United.
Additionally, companies like Lilly and Nvidia have made investments in Abridge, highlighting ongoing financial activity and interest in biotech advancements.
Updates
Update at 14:09 UTC on 2026-06-12
STAT reported Nonprofit Blood Cancer United acquires cancer drug, Lilly and Nvidia invest in Abridge, and more biotech news.
Sources: STAT